Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson’s disease

•Persons with Parkinson’s disease had a higher oxygen cost of walking than controls.•Stride length, but not caden, was associated with oxygen cost of walking.•This highlights developing exercise programs to reduce the oxygen cost of walking.•Interventions may target increasing stride length to impro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gait & posture 2020-10, Vol.82, p.1-5
Hauptverfasser: Jeng, Brenda, Cederberg, Katie L.J., Lai, Byron, Sasaki, Jeffer E., Bamman, Marcas M., Motl, Robert W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5
container_issue
container_start_page 1
container_title Gait & posture
container_volume 82
creator Jeng, Brenda
Cederberg, Katie L.J.
Lai, Byron
Sasaki, Jeffer E.
Bamman, Marcas M.
Motl, Robert W.
description •Persons with Parkinson’s disease had a higher oxygen cost of walking than controls.•Stride length, but not caden, was associated with oxygen cost of walking.•This highlights developing exercise programs to reduce the oxygen cost of walking.•Interventions may target increasing stride length to improve walking economy. Oxygen (O2) cost of walking is a physiological marker of walking dysfunction and reflects the amount of O2 consumed per kilogram of body weight per unit distance walked. The onset of walking dysfunction (i.e., reduced walking speed and shorter stride length) is commonly observed in Parkinson’s disease (PD), even in the early stages of the disease. However, the O2 cost of walking has not been assessed in persons with PD. Does O2 cost of walking differ between persons with PD and controls matched by age and sex? The sample included 31 persons with mild-to-moderate PD (Hoehn and Yahr stages 2–3) and 31 age- and sex-matched controls in this cross-sectional study. O2 consumption (VO2) was measured using a portable indirect calorimetry system during a 6-min period of over-ground walking at a normal comfortable speed, and the O2 cost of walking was calculated based on the ratio of net relative VO2 (ml kg−1 min−1) and speed (m min−1). There were no differences in resting VO2, steady-state VO2, and over-ground walking speed between persons with PD and controls (p > 0.05). There was a significant difference in the O2 cost of walking between persons with PD and healthy controls (p < 0.01) such that persons with PD had a higher O2 cost of walking. The mean(SD) O2 cost of walking for persons with PD was 0.179 (0.038) ml kg−1 m−1, and the O2 cost of walking for healthy controls was 0.153 (0.024) ml kg−1 m−1. Persons with PD demonstrated a higher O2 cost of walking compared with controls, and this may reflect worse walking economy in PD. The possibility of worse walking economy under free-living conditions may result in reduced community ambulation and participation.
doi_str_mv 10.1016/j.gaitpost.2020.08.108
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7718302</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0966636220304999</els_id><sourcerecordid>2437121023</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-2ba9c0636ea35d8245f386ff0fa556dd4bb24694fe53e5d87b44c0c0fbefd67d3</originalsourceid><addsrcrecordid>eNqFkU1uFDEQhS0EIkPgCpGXbHrwX7vdGwSKwo8UKSxgwcpy2-WOh257sHsmZMc1cr2cBEeTRLBiVVLVV6-e6iF0QsmaEirfbNajCcs2lWXNCCNrompfPUErqrq-YYz2T9GK9FI2kkt2hF6UsiGECK7Yc3TEmeKSMLlC3y9-XY8Qsa1KOHmc9pCbMadddPjKTD9CHHGIeAu5pFjwVVgu8Rwm1yypmZODbBbAX0yuYAVuf98U7EIBU-AleubNVODVfT1G3z6cfT391JxffPx8-v68saKjS8MG01tSTYLhrVNMtJ4r6T3xpm2lc2IYmJC98NByqEA3CGGJJX4A72Tn-DF6e9Dd7oYZnIW4ZDPpbQ6zydc6maD_ncRwqce0111HFSesCry-F8jp5w7KoudQLEyTiZB2RTPBO8poJSsqD6jNqZQM_vEMJfouF73RD7nou1w0UbWv6uLJ3yYf1x6CqMC7AwD1VfsAWRcbIFpwIYNdtEvhfzf-AG_Tppo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2437121023</pqid></control><display><type>article</type><title>Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson’s disease</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Jeng, Brenda ; Cederberg, Katie L.J. ; Lai, Byron ; Sasaki, Jeffer E. ; Bamman, Marcas M. ; Motl, Robert W.</creator><creatorcontrib>Jeng, Brenda ; Cederberg, Katie L.J. ; Lai, Byron ; Sasaki, Jeffer E. ; Bamman, Marcas M. ; Motl, Robert W.</creatorcontrib><description>•Persons with Parkinson’s disease had a higher oxygen cost of walking than controls.•Stride length, but not caden, was associated with oxygen cost of walking.•This highlights developing exercise programs to reduce the oxygen cost of walking.•Interventions may target increasing stride length to improve walking economy. Oxygen (O2) cost of walking is a physiological marker of walking dysfunction and reflects the amount of O2 consumed per kilogram of body weight per unit distance walked. The onset of walking dysfunction (i.e., reduced walking speed and shorter stride length) is commonly observed in Parkinson’s disease (PD), even in the early stages of the disease. However, the O2 cost of walking has not been assessed in persons with PD. Does O2 cost of walking differ between persons with PD and controls matched by age and sex? The sample included 31 persons with mild-to-moderate PD (Hoehn and Yahr stages 2–3) and 31 age- and sex-matched controls in this cross-sectional study. O2 consumption (VO2) was measured using a portable indirect calorimetry system during a 6-min period of over-ground walking at a normal comfortable speed, and the O2 cost of walking was calculated based on the ratio of net relative VO2 (ml kg−1 min−1) and speed (m min−1). There were no differences in resting VO2, steady-state VO2, and over-ground walking speed between persons with PD and controls (p &gt; 0.05). There was a significant difference in the O2 cost of walking between persons with PD and healthy controls (p &lt; 0.01) such that persons with PD had a higher O2 cost of walking. The mean(SD) O2 cost of walking for persons with PD was 0.179 (0.038) ml kg−1 m−1, and the O2 cost of walking for healthy controls was 0.153 (0.024) ml kg−1 m−1. Persons with PD demonstrated a higher O2 cost of walking compared with controls, and this may reflect worse walking economy in PD. The possibility of worse walking economy under free-living conditions may result in reduced community ambulation and participation.</description><identifier>ISSN: 0966-6362</identifier><identifier>EISSN: 1879-2219</identifier><identifier>DOI: 10.1016/j.gaitpost.2020.08.108</identifier><identifier>PMID: 32836026</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Aged ; Cross-Sectional Studies ; Energy expenditure ; Energy Metabolism - physiology ; Female ; Humans ; Male ; Middle Aged ; Oxygen - economics ; Oxygen Consumption - physiology ; Parkinson Disease - economics ; Parkinson Disease - therapy ; Parkinson’s disease ; Rehabilitation ; Walking ; Walking - physiology</subject><ispartof>Gait &amp; posture, 2020-10, Vol.82, p.1-5</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-2ba9c0636ea35d8245f386ff0fa556dd4bb24694fe53e5d87b44c0c0fbefd67d3</citedby><cites>FETCH-LOGICAL-c471t-2ba9c0636ea35d8245f386ff0fa556dd4bb24694fe53e5d87b44c0c0fbefd67d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.gaitpost.2020.08.108$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32836026$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jeng, Brenda</creatorcontrib><creatorcontrib>Cederberg, Katie L.J.</creatorcontrib><creatorcontrib>Lai, Byron</creatorcontrib><creatorcontrib>Sasaki, Jeffer E.</creatorcontrib><creatorcontrib>Bamman, Marcas M.</creatorcontrib><creatorcontrib>Motl, Robert W.</creatorcontrib><title>Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson’s disease</title><title>Gait &amp; posture</title><addtitle>Gait Posture</addtitle><description>•Persons with Parkinson’s disease had a higher oxygen cost of walking than controls.•Stride length, but not caden, was associated with oxygen cost of walking.•This highlights developing exercise programs to reduce the oxygen cost of walking.•Interventions may target increasing stride length to improve walking economy. Oxygen (O2) cost of walking is a physiological marker of walking dysfunction and reflects the amount of O2 consumed per kilogram of body weight per unit distance walked. The onset of walking dysfunction (i.e., reduced walking speed and shorter stride length) is commonly observed in Parkinson’s disease (PD), even in the early stages of the disease. However, the O2 cost of walking has not been assessed in persons with PD. Does O2 cost of walking differ between persons with PD and controls matched by age and sex? The sample included 31 persons with mild-to-moderate PD (Hoehn and Yahr stages 2–3) and 31 age- and sex-matched controls in this cross-sectional study. O2 consumption (VO2) was measured using a portable indirect calorimetry system during a 6-min period of over-ground walking at a normal comfortable speed, and the O2 cost of walking was calculated based on the ratio of net relative VO2 (ml kg−1 min−1) and speed (m min−1). There were no differences in resting VO2, steady-state VO2, and over-ground walking speed between persons with PD and controls (p &gt; 0.05). There was a significant difference in the O2 cost of walking between persons with PD and healthy controls (p &lt; 0.01) such that persons with PD had a higher O2 cost of walking. The mean(SD) O2 cost of walking for persons with PD was 0.179 (0.038) ml kg−1 m−1, and the O2 cost of walking for healthy controls was 0.153 (0.024) ml kg−1 m−1. Persons with PD demonstrated a higher O2 cost of walking compared with controls, and this may reflect worse walking economy in PD. The possibility of worse walking economy under free-living conditions may result in reduced community ambulation and participation.</description><subject>Aged</subject><subject>Cross-Sectional Studies</subject><subject>Energy expenditure</subject><subject>Energy Metabolism - physiology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Oxygen - economics</subject><subject>Oxygen Consumption - physiology</subject><subject>Parkinson Disease - economics</subject><subject>Parkinson Disease - therapy</subject><subject>Parkinson’s disease</subject><subject>Rehabilitation</subject><subject>Walking</subject><subject>Walking - physiology</subject><issn>0966-6362</issn><issn>1879-2219</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1uFDEQhS0EIkPgCpGXbHrwX7vdGwSKwo8UKSxgwcpy2-WOh257sHsmZMc1cr2cBEeTRLBiVVLVV6-e6iF0QsmaEirfbNajCcs2lWXNCCNrompfPUErqrq-YYz2T9GK9FI2kkt2hF6UsiGECK7Yc3TEmeKSMLlC3y9-XY8Qsa1KOHmc9pCbMadddPjKTD9CHHGIeAu5pFjwVVgu8Rwm1yypmZODbBbAX0yuYAVuf98U7EIBU-AleubNVODVfT1G3z6cfT391JxffPx8-v68saKjS8MG01tSTYLhrVNMtJ4r6T3xpm2lc2IYmJC98NByqEA3CGGJJX4A72Tn-DF6e9Dd7oYZnIW4ZDPpbQ6zydc6maD_ncRwqce0111HFSesCry-F8jp5w7KoudQLEyTiZB2RTPBO8poJSsqD6jNqZQM_vEMJfouF73RD7nou1w0UbWv6uLJ3yYf1x6CqMC7AwD1VfsAWRcbIFpwIYNdtEvhfzf-AG_Tppo</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Jeng, Brenda</creator><creator>Cederberg, Katie L.J.</creator><creator>Lai, Byron</creator><creator>Sasaki, Jeffer E.</creator><creator>Bamman, Marcas M.</creator><creator>Motl, Robert W.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201001</creationdate><title>Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson’s disease</title><author>Jeng, Brenda ; Cederberg, Katie L.J. ; Lai, Byron ; Sasaki, Jeffer E. ; Bamman, Marcas M. ; Motl, Robert W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-2ba9c0636ea35d8245f386ff0fa556dd4bb24694fe53e5d87b44c0c0fbefd67d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Cross-Sectional Studies</topic><topic>Energy expenditure</topic><topic>Energy Metabolism - physiology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Oxygen - economics</topic><topic>Oxygen Consumption - physiology</topic><topic>Parkinson Disease - economics</topic><topic>Parkinson Disease - therapy</topic><topic>Parkinson’s disease</topic><topic>Rehabilitation</topic><topic>Walking</topic><topic>Walking - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jeng, Brenda</creatorcontrib><creatorcontrib>Cederberg, Katie L.J.</creatorcontrib><creatorcontrib>Lai, Byron</creatorcontrib><creatorcontrib>Sasaki, Jeffer E.</creatorcontrib><creatorcontrib>Bamman, Marcas M.</creatorcontrib><creatorcontrib>Motl, Robert W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Gait &amp; posture</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jeng, Brenda</au><au>Cederberg, Katie L.J.</au><au>Lai, Byron</au><au>Sasaki, Jeffer E.</au><au>Bamman, Marcas M.</au><au>Motl, Robert W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson’s disease</atitle><jtitle>Gait &amp; posture</jtitle><addtitle>Gait Posture</addtitle><date>2020-10-01</date><risdate>2020</risdate><volume>82</volume><spage>1</spage><epage>5</epage><pages>1-5</pages><issn>0966-6362</issn><eissn>1879-2219</eissn><abstract>•Persons with Parkinson’s disease had a higher oxygen cost of walking than controls.•Stride length, but not caden, was associated with oxygen cost of walking.•This highlights developing exercise programs to reduce the oxygen cost of walking.•Interventions may target increasing stride length to improve walking economy. Oxygen (O2) cost of walking is a physiological marker of walking dysfunction and reflects the amount of O2 consumed per kilogram of body weight per unit distance walked. The onset of walking dysfunction (i.e., reduced walking speed and shorter stride length) is commonly observed in Parkinson’s disease (PD), even in the early stages of the disease. However, the O2 cost of walking has not been assessed in persons with PD. Does O2 cost of walking differ between persons with PD and controls matched by age and sex? The sample included 31 persons with mild-to-moderate PD (Hoehn and Yahr stages 2–3) and 31 age- and sex-matched controls in this cross-sectional study. O2 consumption (VO2) was measured using a portable indirect calorimetry system during a 6-min period of over-ground walking at a normal comfortable speed, and the O2 cost of walking was calculated based on the ratio of net relative VO2 (ml kg−1 min−1) and speed (m min−1). There were no differences in resting VO2, steady-state VO2, and over-ground walking speed between persons with PD and controls (p &gt; 0.05). There was a significant difference in the O2 cost of walking between persons with PD and healthy controls (p &lt; 0.01) such that persons with PD had a higher O2 cost of walking. The mean(SD) O2 cost of walking for persons with PD was 0.179 (0.038) ml kg−1 m−1, and the O2 cost of walking for healthy controls was 0.153 (0.024) ml kg−1 m−1. Persons with PD demonstrated a higher O2 cost of walking compared with controls, and this may reflect worse walking economy in PD. The possibility of worse walking economy under free-living conditions may result in reduced community ambulation and participation.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>32836026</pmid><doi>10.1016/j.gaitpost.2020.08.108</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0966-6362
ispartof Gait & posture, 2020-10, Vol.82, p.1-5
issn 0966-6362
1879-2219
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7718302
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Aged
Cross-Sectional Studies
Energy expenditure
Energy Metabolism - physiology
Female
Humans
Male
Middle Aged
Oxygen - economics
Oxygen Consumption - physiology
Parkinson Disease - economics
Parkinson Disease - therapy
Parkinson’s disease
Rehabilitation
Walking
Walking - physiology
title Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson’s disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T08%3A23%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxygen%20cost%20of%20over-ground%20walking%20in%20persons%20with%20mild-to-moderate%20Parkinson%E2%80%99s%20disease&rft.jtitle=Gait%20&%20posture&rft.au=Jeng,%20Brenda&rft.date=2020-10-01&rft.volume=82&rft.spage=1&rft.epage=5&rft.pages=1-5&rft.issn=0966-6362&rft.eissn=1879-2219&rft_id=info:doi/10.1016/j.gaitpost.2020.08.108&rft_dat=%3Cproquest_pubme%3E2437121023%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2437121023&rft_id=info:pmid/32836026&rft_els_id=S0966636220304999&rfr_iscdi=true